McAdam LLC Has $748,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

McAdam LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,063 shares of the exchange traded fund’s stock after selling 3,105 shares during the quarter. McAdam LLC’s holdings in SPDR S&P Biotech ETF were worth $748,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. HBK Sorce Advisory LLC raised its holdings in SPDR S&P Biotech ETF by 2.6% in the 1st quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after acquiring an additional 113 shares in the last quarter. Intellectus Partners LLC raised its stake in SPDR S&P Biotech ETF by 1.0% in the second quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares in the last quarter. Concourse Financial Group Securities Inc. lifted its position in SPDR S&P Biotech ETF by 21.2% during the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after purchasing an additional 115 shares during the period. Pacific Center for Financial Services grew its stake in SPDR S&P Biotech ETF by 2.8% during the first quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after buying an additional 118 shares in the last quarter. Finally, Kingsview Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 3.8% in the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after buying an additional 127 shares during the period.

SPDR S&P Biotech ETF Trading Up 1.4 %

Shares of SPDR S&P Biotech ETF stock opened at $101.51 on Friday. The company has a 50 day moving average of $96.10 and a 200-day moving average of $93.22. The company has a market cap of $7.74 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.